FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis

The WNT/β-catenin pathway plays an important role in pancreatic cancer carcinogenesis. We evaluated the correlation between aberrant β-catenin pathway activation and the prognosis pancreatic cancer, and the potential of applying the β-catenin pathway inhibitor FH535 to pancreatic cancer treatment. M...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Liu, Lu, Zhi, Qiaoming, Shen, Meng, Gong, Fei-Ran, Zhou, Binhua P., Lian, Lian, Shen, Bairong, Chen, Kai, Duan, Weiming, Wu, Meng-Yao, Tao, Min, Li, Wei
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2016
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5216931/
https://ncbi.nlm.nih.gov/pubmed/27323403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9975
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi